Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Enhanced detection of circulating tumor DNA by fragment size analysis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Distinct immune phenotypes in infants developing asthma during childhood

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Filamentous bacteriophages are associated with chronic Pseudomonas lung infections and antibiotic resistance in cystic fibrosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Direct detection of early-stage cancers using circulating tumor DNA

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Florent Mouliere
  • Dineika Chandrananda
  • Anna M Piskorz
  • Elizabeth K Moore
  • James Morris
  • Lise Barlebo Ahlborn
  • Richard Mair
  • Teodora Goranova
  • Francesco Marass
  • Katrin Heider
  • Jonathan C M Wan
  • Anna Supernat
  • Irena Hudecova
  • Ioannis Gounaris
  • Susana Ros
  • Mercedes Jimenez-Linan
  • Javier Garcia-Corbacho
  • Keval Patel
  • Olga Østrup
  • Suzanne Murphy
  • Matthew D Eldridge
  • Davina Gale
  • Grant D Stewart
  • Johanna Burge
  • Wendy N Cooper
  • Michiel S van der Heijden
  • Charles E Massie
  • Colin Watts
  • Pippa Corrie
  • Simon Pacey
  • Kevin M Brindle
  • Richard D Baird
  • Morten Mau-Sørensen
  • Christine A Parkinson
  • Christopher G Smith
  • James D Brenton
  • Nitzan Rosenfeld
Vis graf over relationer

Existing methods to improve detection of circulating tumor DNA (ctDNA) have focused on genomic alterations but have rarely considered the biological properties of plasma cell-free DNA (cfDNA). We hypothesized that differences in fragment lengths of circulating DNA could be exploited to enhance sensitivity for detecting the presence of ctDNA and for noninvasive genomic analysis of cancer. We surveyed ctDNA fragment sizes in 344 plasma samples from 200 patients with cancer using low-pass whole-genome sequencing (0.4×). To establish the size distribution of mutant ctDNA, tumor-guided personalized deep sequencing was performed in 19 patients. We detected enrichment of ctDNA in fragment sizes between 90 and 150 bp and developed methods for in vitro and in silico size selection of these fragments. Selecting fragments between 90 and 150 bp improved detection of tumor DNA, with more than twofold median enrichment in >95% of cases and more than fourfold enrichment in >10% of cases. Analysis of size-selected cfDNA identified clinically actionable mutations and copy number alterations that were otherwise not detected. Identification of plasma samples from patients with advanced cancer was improved by predictive models integrating fragment length and copy number analysis of cfDNA, with area under the curve (AUC) >0.99 compared to AUC <0.80 without fragmentation features. Increased identification of cfDNA from patients with glioma, renal, and pancreatic cancer was achieved with AUC > 0.91 compared to AUC < 0.5 without fragmentation features. Fragment size analysis and selective sequencing of specific fragment sizes can boost ctDNA detection and could complement or provide an alternative to deeper sequencing of cfDNA.

OriginalsprogEngelsk
TidsskriftScience translational medicine
Vol/bind10
Udgave nummer466
Sider (fra-til) eaat4921
ISSN1946-6234
DOI
StatusUdgivet - 7 nov. 2018

ID: 55864434